Antagonists of the Human A2A Adenosine Receptor. 4. Design, Synthesis, and Preclinical Evaluation of 7-Aryltriazolo[4,5-d]pyrimidines-Reference-Cited by-同舟云学术

Antagonists of the Human A2A Adenosine Receptor. 4. Design, Synthesis, and Preclinical Evaluation of 7-Aryltriazolo[4,5-d]pyrimidines

Published:2008-12-10 Issue:1 Volume:52 Page:33-47
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Gillespie Roger J.¹,Bamford Samantha J.¹,Botting Ruth¹,Comer Mike¹,Denny Sarah¹,Gaur Suneel¹,Griffin Michael¹,Jordan Allan M.¹,Knight Anthony R.¹,Lerpiniere Joanne¹,Leonardi Stefania¹,Lightowler Sean¹,McAteer Steven¹,Merrett Angela¹,Misra Anil¹,Padfield Antony¹,Reece Mark¹,Saadi Mona¹,Selwood Daniel L.¹,Stratton Gemma C.¹,Surry Dominic¹,Todd Richard¹,Tong Xin¹,Ruston Vicki¹,Upton Rebecca¹,Weiss Scott M.¹

Affiliation:

1. Vernalis (R&D) Ltd., Oakdene House, 613 Reading Road, Winnersh, Wokingham RG41 5UA, U.K., and Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm800961g

Reference48 articles.

1. Parkinson's disease: clinical features and diagnosis

2. Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations

3. Glutamate and Parkinson’s disease

4. Modification of Parkinsonism — Chronic Treatment with L-Dopa

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists;Molecules;2024-08-14

2. Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms;Neurological Sciences;2024-02-23

3. Novel Quinazoline Derivatives as Highly Effective a 2a Adenosine Receptor Antagonists;2024

4. Adenosine A_2A Receptor (A_2AAR) Ligand Screening Using the ¹⁹F-NMR Probe FPPA;Journal of the American Chemical Society;2023-06-05

5. New paradigms in purinergic receptor ligand discovery;Neuropharmacology;2023-06